Skip to content
Financing

Proceeds from (repayments of) short-term borrowings, net

Boston Scientific Proceeds from (repayments of) short-term borrowings, net increased by 100.0% to $0 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$192M to $0.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2015
Last reportedQ1 2026May 1, 2026

How to read this metric

Positive values indicate increased reliance on short-term debt for liquidity; negative values indicate a reduction in short-term debt exposure.

Detailed definition

The net cash flow resulting from the issuance and repayment of commercial paper, which are short-term, unsecured promiss...

Peer comparison

Common for large-cap companies with active treasury management and high credit ratings.

Metric ID: financing_proceeds_from_repayments_of_commercial_paper

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$0$0$0$223M-$155M$0$37M-$41M$0$0$0$0$187M-$192M$0
QoQ Change-169.5%+100.0%-210.8%+100.0%-202.7%+100.0%
YoY Change-100.0%+73.5%-100.0%+100.0%+100.0%
Range-$192M$223M
Avg YoY Growth+14.7%
Median YoY Growth+73.5%

Proceeds from (repayments of) short-term borrowings, net at Other Companies

Frequently Asked Questions

What is Boston Scientific's proceeds from (repayments of) short-term borrowings, net?
Boston Scientific (BSX) reported proceeds from (repayments of) short-term borrowings, net of $0 in Q1 2026.
How has Boston Scientific's proceeds from (repayments of) short-term borrowings, net changed year-over-year?
Boston Scientific's proceeds from (repayments of) short-term borrowings, net increased by 100.0% year-over-year, from -$192M to $0.
What does proceeds from (repayments of) short-term borrowings, net mean?
Net cash changes from short-term commercial paper borrowing.